| HOME >> BIOLOGY >> TECHNOLOGY |
-------------------------------------------------------------------------
Total current liabilities 3,267,679 3,489,361
-------------------------------------------------------------------------
Long-term debt 1,128,337 1,280,916
Long-term portion of deferred revenue 100,876 401,371
-------------------------------------------------------------------------
Total liabilities 4,496,892 5,171,648
-------------------------------------------------------------------------
Shareholders' equity
Capital stock 44,321,680 44,290,930
Contributed surplus 2,875,837 2,733,562
Deficit (35,934,440) (33,348,130)
-------------------------------------------------------------------------
Total shareholders' equity 11,263,077 13,676,362
-------------------------------------------------------------------------
15,759,968 18,848,010
-------------------------------------------------------------------------
-------------------------------------------------------------------------
CONSOLIDATED STATEMENTS OF OPERATIONS
AND DEFICIT
(Unaudited)
(Expressed in Canadian dollars)
Three month period ended March 31
2008 2007
$ $
-------------------------------------------------------------------------
REVENUE
Milestone revenue
'/>"/>
| SOURCE GeneNews Limited Copyright©2008 PR Newswire. All rights reserved |